937K shares, 2.2M marketcap micro float. ADHD 1 dose medicine advancing through trials with FDA guidance. I wouldn't be surprised to see ARCT, DRRX, or NNLSP buy them up! Do your own due diligence. Do not take this as financial advice. I own shares in this company.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.